38
Views
1
CrossRef citations to date
0
Altmetric
Review

Occupational asthma: risk factors, diagnosis and preventive measures

Pages 123-132 | Published online: 10 Jan 2014

References

  • Wagner GR, Wegman DH. Occupational asthma: prevention by definition. Am. J. Ind. Med. 33, 427–429 (1998).
  • Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 88, 376–384 (1985).
  • Bernstein IL, Chan Yeung M, Malo J-L, Bernstein DI. Asthma in the Workplace. Marcel Dekker, Inc., NY, USA (1999).
  • Mapp CE, Saetta M, Maestrelli P, Fabbri L. Occupational asthma. European Respiratory Monograph 11, 255–285 (1999).
  • Maestrelli P, Del Prete GF, De Carli M et al. CD8 T-cell clones producing interleukin-5 and interferon-γ in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand. J. Work Environ. Health 20, 376–381 (1994).
  • Frew A, Chang JH, Chan H et al. T-lymphocyte responses to plicatic acid–human serum albumin conjugate in occupational asthma caused by western red cedar. J. Allergy Clin. Immunol. 101, 841–847 (1998).
  • Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-α by peripheral mononuclear cells of workers with occupational asthma. J. Allergy Clin. Immunol. 102, 265–274 (1998).
  • Lemiere C, Pelissier S, Tremblay C et al. Leukotrienes and isocyanate-induced asthma: a pilot study. Clin. Exp. Allergy 34, 1684–1689 (2004).
  • Mapp CE, Lucchini RE, Miotto D et al. Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea-pig central airways. Am. J. Respir. Crit. Care Med. 158, 263–269 (1998).
  • Blanc PD, Toren K. How much adult asthma can be attributed to occupational factors? Am. J. Med. 107, 580–587 (1999).
  • Kogevinas M, Anto JM, Sunyer J, Tobias A, Kromhout H, Burney P. Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet 353, 1750–1754 (1999).
  • Jaakkola JJ, Piipari R, Jaakkola MS. Occupation and asthma: a population-based incident case-control study. Am. J. Epidemiol. 158, 981–987 (2003).
  • Draper A, Newman Taylor A, Cullinan P. Estimating the incidence of occupational asthma and rhinitis from laboratory animal allergens in the UK, 1999–2000. Occup. Environ. Med. 60, 604–605 (2003).
  • Ameille J, Pauli G, Calastreng-Crinquand A et al. Reported incidence of occupational asthma in France, 1996–1999: the ONAP programme. Occup. Environ. Med. 60, 136–141 (2003).
  • Karjalainen A, Kurppa K, Virtanen S, Keskinen H, Nordman H. Incidence of occupational asthma by occupation and industry in Finland. Am. J. Ind. Med. 37, 451–458 (2000).
  • Meredith SK, Taylor VM, McDonald JC. Occupational respiratory disease in the United Kingdom 1989: a report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br. J. Ind. Med. 48, 292–298 (1991).
  • Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German healthcare system through education and intervention. J. Allergy Clin. Immunol. 110, 318–323 (2002).
  • Cathcart M, Nicholson P, Roberts D et al. Enzyme exposure, smoking and lung function in employees in the detergent industry over 20 years. Medical subcommittee of the UK Soap and Detergent Industry Association. Occup. Med. (Lond.) 47, 473–478 (1997).
  • Brisman J, Jarvholm B, Lillienberg L. Exposure–response relations for self reported asthma and rhinitis in bakers. Occup. Environ. Med. 57, 335–340 (2000).
  • Cullinan P, Cook A, Gordon S et al. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur. Respir. J. 13, 1139–1143 (1999).
  • Cullinan P, Cook A, Nieuwenhuijsen MJ et al. Allergen and dust exposure as determinants of work-related symptoms and sensitization in a cohort of flour-exposed workers; a case-control analysis. Ann. Occup. Hyg. 45, 97–103 (2001).
  • Heederik D, Houba R. An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann. Occup. Hyg. 45, 175–185 (2001).
  • Kruize H, Post W, Heederik D, Martens B, Hollander A, van der Beek E. Respiratory allergy in laboratory animal workers: a retrospective cohort study using pre-employment screening data. Occup. Environ. Med. 54, 830–835 (1997).
  • Liss GM, Tarlo SM. Peak expiratory flow rates in possible occupational asthma. Chest 100, 1480 (1991).
  • Meredith SK, Bugler J, Clark RL. Isocyanate exposure and occupational asthma: a case-referent study. Occup. Environ. Med. 57, 830–836 (2000).
  • Tarlo SM, Liss GM, Dias C, Banks DE. Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am. J. Ind. Med. 32, 517–521 (1997).
  • Cullinan P, MacNeill SJ, Harris JM et al. Early allergen exposure, skin prick responses, and atopic wheeze at age 5 in English children: a cohort study. Thorax 59, 855–861 (2004).
  • Botham PA, Davies GE, Teasdale EL. Allergy to laboratory animals: a prospective study of its incidence and of the influence of atopy on its development. Br. J. Ind. Med. 44, 627–632 (1987).
  • Droste J, Myny K, Van Sprundel M et al. Allergic sensitization, symptoms, and lung function among bakery workers as compared with a nonexposed work population. J. Occup. Environ. Med. 45, 648–655 (2003).
  • Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am. J. Respir. Crit. Care Med. 163, 899–904 (2001).
  • Mapp CE, Fryer AA, De Marzo N et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J. Allergy Clin. Immunol. 109, 867–872 (2002).
  • Piirila P, Wikman H, Luukkonen R et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 11, 437–445 (2001).
  • Wikman H, Piirila P, Rosenberg C et al. N-acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 12, 227–233 (2002).
  • Jeal H, Draper A, Jones M et al. HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies? J. Allergy Clin. Immunol. 111, 795–799 (2003).
  • Newman Taylor AJ, Cullinan P, Lympany PA, Harris JM, Dowdeswell RJ, du Bois RM. Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am. J. Respir. Crit. Care Med. 160, 435–438 (1999).
  • Calverley AE, Rees D, Dowdeswell RJ, Linnett PJ, Kielkowski D. Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposure. Occup. Environ. Med. 52, 661–666 (1995).
  • Cullen MR, Redlich CA, Beckett WS et al. Feasibility study of respiratory questionnaire and peak flow recordings in autobody shop workers exposed to isocyanate-containing spray paint: observations and limitations. Occup. Med. (Lond.) 46, 197–204 (1996).
  • Venables KM, Dally MB, Nunn AJ et al. Smoking and occupational allergy in workers in a platinum refinery. Br. Med. J. 299, 939–942 (1989).
  • Bright P, Newton DT, Gannon PF, Pantin CF, Burge PS. OASYS-3: improved analysis of serial peak expiratory flow in suspected occupational asthma. Monaldi Arch. Chest Dis. 56, 281–288 (2001).
  • Cote J, Kennedy S, Chan-Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J. Allergy Clin. Immunol. 85, 592–598 (1990).
  • Cote J, Kennedy S, Chan-Yeung M. Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax 48, 48–51 (1993).
  • Leroyer C, Perfetti L, Trudeau C, L’Archeveque J, Chan-Yeung M, Malo JL. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. Am. J. Respir. Crit. Care Med. 158, 827–832 (1998).
  • Malo JL, Cote J, Cartier A, Boulet LP, L’Archeveque J, Chan-Yeung M. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Thorax 48, 1211–1217 (1993).
  • Perrin B, Lagier F, L’Archeveque J et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur. Respir. J. 5, 40–48 (1992).
  • Baldwin DR, Gannon P, Bright P et al. Interpretation of occupational peak flow records: level of agreement between expert clinicians and Oasys-2. Thorax 57, 860–864 (2002).
  • Gannon PF, Newton DT, Belcher J, Pantin CF, Burge PS. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax 51, 484–489 (1996).
  • Girard F, Chaboillez S, Cartier A et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am. J. Respir. Crit. Care Med. 170, 845–850 (2004).
  • Tee RD, Cullinan P, Welch J, Burge PS, Newman Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 101, 709–715 (1998).
  • Bernstein DI, Cartier A, Cote J et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am. J. Respir. Crit. Care Med. 166, 445–450 (2002).
  • Lemiere C, Pizzichini MM, Balkissoon R et al. Diagnosing occupational asthma: use of induced sputum. Eur. Respir. J. 13, 482–488 (1999).
  • Lemiere C, Chaboillez S, Malo JL, Cartier A. Changes in sputum cell counts after exposure to occupational agents: what do they mean? J. Allergy Clin. Immunol. 107, 1063–1068 (2001).
  • Obata H, Dittrick M, Chan H, Chan-Yeung M. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur. Respir. J. 13, 489–495 (1999).
  • Park HS, Nahm DH. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin. Exp. Allergy 27, 1145–1150 (1997).
  • Piirila PL, Nordman H, Keskinen HM et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am. J. Respir. Crit. Care Med. 162, 516–522 (2000).
  • Pisati G, Baruffini A, Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br. J. Ind. Med. 50, 60–64 (1993).
  • Tarlo SM, Banks D, Liss G, Broder I. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup. Environ. Med. 54, 756–761 (1997).
  • Malo JL, Ghezzo H. Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am. J. Respir. Crit. Care Med. 169, 1304–1307 (2004).
  • Padoan M, Pozzato V, Simoni M et al. Long-term follow-up of toluene diisocyanate-induced asthma. Eur. Respir. J. 21, 637–640 (2003).
  • Malo JL, Cartier A, Cote J et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am. J. Respir. Crit. Care Med. 153, 953–960 (1996).
  • Barker RD, Harris JM, Welch JA, Venables KM, Newman Taylor AJ. Occupational asthma caused by tetrachlorophthalic anhydride: a 12-year follow-up. J. Allergy Clin. Immunol. 101, 717–719 (1998).
  • Hudson P, Cartier A, Pineau L et al. Follow-up of occupational asthma caused by crab and various agents. J. Allergy Clin. Immunol. 76, 682–688 (1985).
  • Vandenplas O, Delwiche JP, Depelchin S, Sibille Y, Vande WR, Delaunois L. Latex gloves with a lower protein content reduce bronchial reactions in subjects with occupational asthma caused by latex. Am. J. Respir. Crit. Care Med. 151, 887–891 (1995).
  • Laoprasert N, Swanson MC, Jones RT, Schroeder DR, Yunginger JW. Inhalation challenge testing of latex-sensitive healthcare workers and the effectiveness of laminar flow HEPA-filtered helmets in reducing rhinoconjunctival and asthmatic reactions. J. Allergy Clin. Immunol. 102, 998–1004 (1998).
  • Muller-Wening D, Neuhauss M. Protective effect of respiratory devices in farmers with occupational asthma. Eur. Respir. J. 12, 569–572 (1998).
  • Slovak AJ, Orr RG, Teasdale EL. Efficacy of the helmet respirator in occupational asthma due to laboratory animal allergy (LAA). Am. Ind. Hyg. Assoc. J. 46, 411–415 (1985).
  • Palmer KT, Poole J, Rawbone RG, Coggon D. Quantifying the advantages and disadvantages of pre-placement genetic screening. Occup. Environ. Med. 61, 448–453 (2004).
  • Bignon JS, Aron Y, Ju LY et al. HLA class II alleles in isocyanate-induced asthma. Am. J. Respir. Crit. Care Med. 149, 71–75 (1994).
  • Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur. Respir. J. 9, 207–210 (1996).
  • Rihs HP, Barbalho-Krolls T, Huber H, Baur X. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am. J. Ind. Med. 32, 522–527 (1997).
  • Mapp CE, Beghe B, Balboni A et al. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin. Exp. Allergy 30, 651–656 (2000).
  • Horne C, Quintana PJ, Keown PA, Dimich-Ward H, Chan-Yeung M. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur. Respir. J. 15, 911–914 (2000).
  • Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am. J. Respir. Crit. Care Med. 151, 219–221 (1995).
  • Drexler H, Schaller KH, Nielsen J et al. Efficacy of measures of hygiene in workers sensitised to acid anhydrides and the influence of selection bias on the results. Occup. Environ. Med. 56, 202–205 (1999).
  • Liss GM, Bernstein D, Genesove L, Roos JO, Lim J. Assessment of risk factors for IgE-mediated sensitization to tetrachlorophthalic anhydride. J. Allergy Clin. Immunol. 92, 237–247 (1993).
  • Hunt LW, Kelkar P, Reed CE, Yunginger JW. Management of occupational allergy to natural rubber latex in a medical center: the importance of quantitative latex allergen measurement and objective follow-up. J. Allergy Clin. Immunol. 110, S96–S106 (2002).
  • Saary MJ, Kanani A, Alghadeer H, Holness DL, Tarlo SM. Changes in rates of natural rubber latex sensitivity among dental school students and staff members after changes in latex gloves. J. Allergy Clin. Immunol. 109, 131–135 (2002).
  • Tarlo SM, Easty A, Eubanks K et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J. Allergy Clin. Immunol. 108, 628–633 (2001).
  • Fisher R, Saunders WB, Murray SJ, Stave GM. Prevention of laboratory animal allergy. J. Occup. Environ. Med. 40, 609–613 (1998).
  • Botham PA, Lamb CT, Teasdale EL, Bonner SM, Tomenson JA. Allergy to laboratory animals: a follow-up study of its incidence and of the influence of atopy and pre-existing sensitisation on its development. Occup. Environ. Med. 52, 129–133 (1995).
  • Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup. Environ. Med. 59, 58–62 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.